Opaleye Management Inc. Liquidia Corp Transaction History
Opaleye Management Inc.
- $364 Million
- Q1 2025
A detailed history of Opaleye Management Inc. transactions in Liquidia Corp stock. As of the latest transaction made, Opaleye Management Inc. holds 2,260,000 shares of LQDA stock, worth $42.5 Million. This represents 9.17% of its overall portfolio holdings.
Number of Shares
2,260,000
Previous 1,698,142
33.09%
Holding current value
$42.5 Million
Previous $20 Million
66.93%
% of portfolio
9.17%
Previous 3.93%
Shares
16 transactions
Others Institutions Holding LQDA
# of Institutions
189Shares Held
45.2MCall Options Held
473KPut Options Held
464K-
Black Rock Inc. New York, NY4.24MShares$79.7 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.99MShares$75 Million0.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.47MShares$65.1 Million0.0% of portfolio
-
Findell Capital Management LLC New York, NY2.89MShares$54.3 Million20.5% of portfolio
-
State Street Corp Boston, MA1.79MShares$33.6 Million0.0% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $1.21B
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...